We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+12.52%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$427M
AUM Growth
+$187M
Cap. Flow
+$161M
Cap. Flow %
37.84%
Top 10 Hldgs %
59.81%
Holding
55
New
16
Increased
13
Reduced
16
Closed
8

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$15.3M
2
CRL icon
Charles River Laboratories
CRL
+$5.97M
3
EW icon
Edwards Lifesciences
EW
+$5.88M
4
BAX icon
Baxter International
BAX
+$5.29M
5
AVTR icon
Avantor
AVTR
+$5.09M

Top Sells

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$6.88M
2
MDT icon
Medtronic
MDT
+$6.59M
3
THC icon
Tenet Healthcare
THC
+$6.29M
4
ZBH icon
Zimmer Biomet
ZBH
+$6.08M
5
DVA icon
DaVita
DVA
+$4.71M

Sector Composition

Rank Sector Weight
1 Healthcare 57.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XBI icon
1
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$28.5M 6.67%
300,000
+164,412
+121% +$15.3M
LLY icon
2
Eli Lilly
LLY
$1.06T
$12.4M 2.92%
16,000
+1,000
+7% +$712K
NVO
3
Novo Nordisk
NVO
$209B
$11.9M 2.78%
92,500
+2,500
+3% +$298K
BSX icon
4
Boston Scientific
BSX
$71.5B
$9.25M 2.17%
135,000
-25,000
-16% -$1.61M
TMO icon
5
Thermo Fisher Scientific
TMO
$220B
$9.01M 2.11%
15,500
+3,500
+29% +$1.96M
SYK icon
6
Stryker
SYK
$130B
$8.95M 2.1%
25,000
-3,000
-11% -$1.01M
ISRG icon
7
Intuitive Surgical
ISRG
$134B
$7.98M 1.87%
20,000
-2,500
-11% -$945K
THC icon
8
Tenet Healthcare
THC
$21.1B
$7.88M 1.85%
75,000
-70,000
-48% -$6.29M
MCK icon
9
McKesson
MCK
$101B
$7.78M 1.82%
14,500
-500
-3% -$254K
DHR icon
10
Danaher
DHR
$144B
$7.49M 1.76%
30,000
+5,000
+20% +$1.22M
UHS icon
11
Universal Health Services
UHS
$10.5B
$7.3M 1.71%
40,000
-27,500
-41% -$4.54M
RMD icon
12
ResMed
RMD
$30.7B
$7M 1.64%
35,361
+15,361
+77% +$2.81M
HUM icon
13
Humana
HUM
$46.2B
$6.93M 1.63%
20,000
+5,000
+33% +$1.9M
CRL icon
14
Charles River Laboratories
CRL
$12.8B
$6.77M 1.59%
+25,000
New +$5.97M
EW icon
15
Edwards Lifesciences
EW
$51.7B
$6.69M 1.57%
+70,000
New +$5.88M
SEM
16
DELISTED
Select Medical
SEM
$6.03M 1.41%
371,200
-92,800
-20% -$1.36M
INSP icon
17
Inspire Medical Systems
INSP
$1.74B
$5.91M 1.38%
27,500
– –
HCA icon
18
HCA Healthcare
HCA
$89.5B
$5.84M 1.37%
17,500
-22,500
-56% -$6.88M
ABT icon
19
Abbott
ABT
$187B
$5.68M 1.33%
50,000
-2,500
-5% -$287K
SGRY icon
20
Surgery Partners
SGRY
$2.03B
$5.67M 1.33%
190,000
-10,000
-5% -$313K
BAX icon
21
Baxter International
BAX
$14.2B
$5.56M 1.3%
+130,000
New +$5.29M
ACHC icon
22
Acadia Healthcare
ACHC
$2.94B
$5.54M 1.3%
70,000
-20,000
-22% -$1.64M
AVTR icon
23
Avantor
AVTR
$9.19B
$5.47M 1.28%
+213,947
New +$5.09M
SNN icon
24
Smith & Nephew
SNN
$12.6B
$5.2M 1.22%
205,000
+15,000
+8% +$412K
PODD icon
25
Insulet
PODD
$9.79B
$5.14M 1.21%
30,000
+3,500
+13% +$653K
1
2 3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PF
PlanVest Financial Gaithersburg, Maryland $131M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
A
AFBI Miami Beach, Florida $131M AUM
SPWM
Schrum Private Wealth Management St. Augustine, Florida $131M AUM 18.38% 1-Year Est. Return

Sivik Global Healthcare's Q1 2024 Portfolio in Review

As of Q1 2024, Sivik Global Healthcare held 55 positions worth $427M, up 78% from $239M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Sivik Global Healthcare deployed $161M of net new capital in Q1 2024, opening 16 new positions and adding to 13 existing holdings. Its largest new stake was Charles River Laboratories: 25,000 shares worth $6.77M.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, down from 95% a quarter earlier.

On the sell side, the largest reduction was HCA Healthcare, an estimated $6.88M trimmed.

  • Sivik Global Healthcare's largest Q1 2024 buy was Charles River Laboratories: 25,000 shares worth $6.77M.
  • Sivik Global Healthcare added most to State Street SPDR S&P Biotech ETF in Q1 2024, an estimated $15.3M increase.
  • Sivik Global Healthcare's biggest Q1 2024 reduction was HCA Healthcare, cutting an estimated $6.88M.
  • Sivik Global Healthcare fully exited Medtronic in Q1 2024, selling an estimated $6.59M.
  • Sivik Global Healthcare's ten largest holdings make up 60% of its $427M portfolio in Q1 2024.
  • Sivik Global Healthcare opened 16 new positions and closed 8 in Q1 2024.
  • Sivik Global Healthcare's portfolio value rose 78% quarter-over-quarter to $427M.

Based on Sivik Global Healthcare's 13F filing for Q1 2024, filed 1 May 2024.